MedPath

A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men

Phase 1
Recruiting
Conditions
Healthy
Interventions
First Posted Date
2025-04-08
Last Posted Date
2025-04-10
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
60
Registration Number
NCT06916702
Locations
🇩🇪

Charité Research Organisation GmbH, Berlin, Germany

A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo matching BI 3031185
First Posted Date
2024-02-13
Last Posted Date
2024-11-13
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
56
Registration Number
NCT06255340
Locations
🇩🇪

Humanpharmakologisches Zentrum Biberach, Biberach, Germany

© Copyright 2025. All Rights Reserved by MedPath